Impaired myogenic tone in isolated cerebral and coronary resistance arteries from the goto-kakizaki rat model of type 2 diabetes

Journal of Vascular Research

Volumn 49, Issue 3, 2012, Pages 267-278

  Kold Petersen, H ^b   Brondum E ^a,b   Nilsson, H ^b   Flyvbjerg, A ^c   Aalkjaer, C ^b  

^a NEUROSEARCH A S   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Endothelium; Intracellular calcium; Myogenic tone; Resistance arteries; Type 2 diabetes

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; CALCIMYCIN; NITRIC OXIDE; RHO KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; BRAIN ARTERY; BRAIN VASCULAR RESISTANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY VASCULAR RESISTANCE; ENZYME INHIBITION; GOTO KAKIZAKI RAT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AMIDES; ANIMALS; BLOOD GLUCOSE; CALCIUM; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; MALE; MIDDLE CEREBRAL ARTERY; NITRIC OXIDE; PROTEIN KINASE C; PYRIDINES; RATS; RATS, WISTAR; RHO-ASSOCIATED KINASES;

EID: 84859713759     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000335487     Document Type: Article

References (52)

1. Giorda CB, Avogaro A, Maggini M, Lombardo F, Mannucci E, Turco S, Alegiani SS, Raschetti R, Velussi M, Ferrannini E: Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 2007; 38: 1154-1160. (Pubitemid 351664268)
2. Wiernsperger N: Vascular defects in the aetiology of peripheral insulin resistance in diabetes. A critical review of hypotheses and facts. Diabetes Metab Rev 1994; 10: 287-307. (Pubitemid 24306137)
3. Nielsen H, Bonnema SJ, Flyvbjerg A: Effects of diabetes, insulin treatment, and osmolality on contractility of isolated rat resistance arteries. Pharmacol Toxicol 1995; 77: 209-215.
4. Rayman G, Hassan A, Tooke JE: Blood flow in the skin of the foot related to posture in diabetes mellitus. Br Med J (Clin Res Ed) 1986; 292: 87-90.
5. Laight DW, Carrier MJ, Anggard EE: Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy. Diabetes Metab Res Rev 1999; 15: 274-282. (Pubitemid 29454476)
6. Johnson PC: The myogenic response in the microcirculation and its interaction with other control systems. J Hypertens Suppl 1989; 7:S33-S39. (Pubitemid 19265009)
7. Davis MJ: Myogenic response gradient in an arteriolar network. Am J Physiol 1993; 264: H2168-H2179. (Pubitemid 23205991)
8. Meininger GA, Davis MJ: Cellular mechanisms involved in the vascular myogenic response. Am J Physiol 1992; 263:H647-H659.
9. Bayliss WM: On the local reactions of the arterial wall to changes of internal pressure. J Physiol 1902; 28: 220-231.
10. Greenstein AS, Price A, Sonoyama K, Paisley A, Khavandi K, Withers S, Shaw L, Paniagua O, Malik RA, Heagerty AM: Eutrophic remodeling of small arteries in type 1 diabetes mellitus is enabled by metabolic control: a 10-year follow-up study. Hypertension 2009; 54: 134-141.
11. Lorenzi M, Feke GT, Pitler L, Berisha F, Kolodjaschna J, McMeel JW: Defective myogenic response to posture change in retinal vessels of well-controlled type 1 diabetic patients with no retinopathy. Invest Ophthalmol Vis Sci 2010; 51: 6770-6775.
12. Davis MJ, et al (eds): Local Regulation of Microvascular Perfusion. Academic Press, 2008.
13. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: 990-994. (Pubitemid 27485693)
14. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S: Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol 2000; 57: 976-983. (Pubitemid 30253382)
15. Rikitake Y, Kim HH, Huang Z, Seto M, Yano K, Asano T, Moskowitz MA, Liao JK: Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 2005; 36: 2251-2257. (Pubitemid 41429255)
16. Goto Y, Kakizaki M, Masaki N: Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 1976; 119: 85-90.
17. Kelly-Cobbs A, Elgebaly MM, Li W, Ergul A: Pressure-independent cerebrovascular remodelling and changes in myogenic reactivity in diabetic Goto-Kakizaki rat in response to glycaemic control. Acta Physiol (Oxf) 2010; 203: 245-251.
18. Janssen U, Vassiliadou A, Riley SG, Phillips AO, Floege J: The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat. J Nephrol 2004; 17: 769-773. (Pubitemid 41158295)
19. Witte K, Jacke K, Stahrenberg R, Arlt G, Reitenbach I, Schilling L, Lemmer B: Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state. Nitric Oxide 2002; 6: 85-95. (Pubitemid 34848269)
20. Witte K, Reitenbach I, Stolpe K, Schilling L, Kirchengast M, Lemmer B: Effects of the endothelin A receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats. J Cardiovasc Pharmacol 2003; 41: 890-896. (Pubitemid 36706136)
21. Brondum E, Nilsson H, Aalkjaer C: Functional abnormalities in isolated arteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models. Horm Metab Res 2005; 37(suppl 1):56-60.
22. Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW, Fagan SC, Ergul A: Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes 2005; 54: 2638-2644. (Pubitemid 41233585)
23. Ivey ME, Osman N, Little PJ: Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis. Atherosclerosis 2008; 199: 237-247.
24. Wang H, Jiang YW, Zhang WJ, Xu SQ, Liu HL, Yang WY, Lou JN: Differential activations of PKC/PKA related to microvasculopathy in diabetic GK rats. Am J Physiol Endocrinol Metab 2012; 302:E173-E182.
25. Zimmermann PA, Knot HJ, Stevenson AS, Nelson MT: Increased myogenic tone and diminished responsiveness to ATP-sensitive K + channel openers in cerebral arteries from diabetic rats. Circ Res 1997; 81: 996-1004. (Pubitemid 27514949)
26. Sachidanandam K, Hutchinson JR, Elgebaly MM, Mezzetti EM, Dorrance AM, Motamed K, Ergul A: Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1. Am J Physiol Regul Integr Comp Physiol 2009; 296:R952-R959.
27. Kobayashi T, Kamata K: Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br J Pharmacol 1999; 127: 835-842. (Pubitemid 29295341)
28. Matsumoto T, Kobayashi T, Kamata K: Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats. Am J Physiol Heart Circ Physiol 2003; 285:H283-H291. (Pubitemid 36736440)
29. Matsumoto T, Wakabayashi K, Kobayashi T, Kamata K: Alterations in vascular endothelial function in the aorta and mesenteric artery in type II diabetic rats. Can J Physiol Pharmacol 2004; 82: 175-182. (Pubitemid 38621690)
30. Schofield I, Malik R, Izzard A, Austin C, Heagerty A: Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002; 106: 3037-3043. (Pubitemid 35440285)
31. El-Omar MM, Yang ZK, Phillips AO, Shah AM: Cardiac dysfunction in the Goto-Kakizaki rat. A model of type II diabetes mellitus. Basic Res Cardiol 2004; 99: 133-141. (Pubitemid 38325025)
32. Rosen P, Wiernsperger NF: Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress. Diabetes Metab Res Rev 2006; 22: 323-330. (Pubitemid 44070509)
33. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95-105.
34. Sachidanandam K, Harris A, Hutchinson J, Ergul A: Microvascular versus macrovascular dysfunction in type 2 diabetes: differences in contractile responses to endothelin-1. Exp Biol Med 2006; 231: 1016-1021. (Pubitemid 43845570)
35. Didion SP, Lynch CM, Baumbach GL, Faraci FM: Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes. Stroke 2005; 36: 342-347. (Pubitemid 40170820)
36. Doyle ME, Egan JM: Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 2007; 113: 546-593. (Pubitemid 46365961)
37. Idris I, Gray S, Donnelly R: Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 2001; 44: 659-673. (Pubitemid 32846021)
38. Massett MP, Ungvari Z, Csiszar A, Kaley G, Koller A: Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. Am J Physiol Heart Circ Physiol 2002; 283:H2282-H2287. (Pubitemid 35345931)
39. Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM: Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 2008; 57: 460-469.
40. Ungvari Z, Pacher P, Kecskemeti V, Papp G, Szollar L, Koller A: Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2 + channels and protein kinase C. Cardiovasc Res 1999; 43: 1018-1028. (Pubitemid 29413860)
41. Amadio M, Bucolo C, Leggio GM, Drago F, Govoni S, Pascale A: The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. Biochem Pharmacol 2010; 80: 1230-1237.
42. Sandu OA, Ragolia L, Begum N: Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation. Diabetes 2000; 49: 2178-2189.
43. Brondum E, Kold-Petersen H, Nilsson H, Flyvbjerg A, Aalkjaer C: Increased contractility to noradrenaline and normal endothelial function in mesenteric small arteries from the Goto-Kakizaki rat model of type 2 diabetes. J Physiol Sci 2008; 58: 333-339.
44. Szekeres M, Nadasy GL, Kaley G, Koller A: Nitric oxide and prostaglandins modulate pressure-induced myogenic responses of intramural coronary arterioles. J Cardiovasc Pharmacol 2004; 43: 242-249. (Pubitemid 38129683)
45. Bagi Z, Koller A, Kaley G: Superoxide-NO interaction decreases flow-and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 2003; 285:H1404-H1410. (Pubitemid 37169492)
46. De Vriese AS, Verbeuren TJ, Van de Voorde, Lameire NH, Vanhoutte PM: Endothelial dysfunction in diabetes. Br J Pharmacol 2000; 130: 963-974. (Pubitemid 30453529)
47. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Piccoli A, Valentini U, Cimino A, Girelli A, Salvetti M, De Ciuceis C, Tiberio GA, Giulini SM, Sleiman I, Monteduro C, Rosei EA: Endothelial dysfunction in small resistance arteries of patients with non-insulin-dependent diabetes mellitus. J Hypertens 2001; 19: 913-919. (Pubitemid 32436956)
48. Rizzoni D, Rosei EA: Small artery remodeling in diabetes mellitus. Nutr Metab Cardiovasc Dis 2009; 19: 587-592.
49. Brondum E, Kold-Petersen H, Simonsen U, Aalkjaer C: NS309 restores EDHF-type relaxation in mesenteric small arteries from type 2 diabetic ZDF rats. Br J Pharmacol 2010; 159: 154-165.
50. Oltman CL, Richou LL, Davidson EP, Coppey LJ, Lund DD, Yorek MA: Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 2006; 291:H1780-H1787. (Pubitemid 44497684)
51. Peterson RG, Shaw WN, Neel M, Little LA, Eichberg J: Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR J 1990; 32: 16-19.
52. Bohlen HG, Lash JM: Endothelial-dependent vasodilation is preserved in non-insulin-dependent Zucker fatty diabetic rats. Am J Physiol 1995; 268:H2366-H2374.